Switch to
More onapp

Caplin Point Laboratories Ltd

CAPLIPOINT
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,262 cr, stock is ranked 496
Low RiskStock is 1.99x as volatile as Nifty
695.150.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5,262 cr, stock is ranked 496
Low RiskStock is 1.99x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
17.70
PB RatioPB Ratio
3.51
Dividend YieldDiv. Yield
0.57%
Sector PESector PE
33.51
Sector PBSector PB
4.10
Sector Div YldSctr Div Yld
0.94%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers.

Financial TrendFinancial statements 

20192020202120220.670.901.081.310.180.220.240.30
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Loss of Share Certificates 
Announced OnFeb 1, 2023

Caplin Point Laboratories Limited has informed the Exchange about Loss of Share Certificates | Download

Caplin Point Laboratories Limited has informed the Exchange about Loss of Share Certificates | Download

Board Meeting Intimation 
Announced OnJan 28, 2023

CAPLIN POINT LABORATORIES LIMITEDhas informed the Exchange about Board Meeting to be held on 11-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 . | Download

CAPLIN POINT LABORATORIES LIMITEDhas informed the Exchange about Board Meeting to be held on 11-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 . | Download

Cash Dividend 
Ex. DateSep 21, 2022

Final • Div/Share: ₹ 2

See all events